Skip to main content
PMC home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1980 Oct;56(660):738–741. doi: 10.1136/pgmj.56.660.738

Cholestatic jaundice: an immune response to prajmalium bitartrate.

H H Rotmensch, M Liron, I Yust, A Klejman, E Livni, T Moalem, A Gefel
PMCID: PMC2426036  PMID: 7220413

Abstract

Cholestatic jaundice associated with chills, pruritus and blood eosinophilia developed in a patient who received prajmalium bitartrate therapy for ventricular arrhythmia following acute myocardial infarction. Discontinuation of the drug resulted in a spontaneous improvement in the clinical and biochemical findings. Challenge by prajmalium bitartrate caused rapid reappearance of the clinical and biochemical features. In immunological studies, deposits of IgG and IgA were detected at the bile canaliculi by fluorescent staining, and the patient's lymphocytes produced macrophage migration inhibition after in vitro incubation with prajmalium bitartrate. Thus, laboratory results support the assumption of an allergic mechanism.

Full text

PDF
738

Images in this article

740Fig. 2
on p.740
740Fig. 3
on p.740

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Buscher H. P., Talke H., Rademacher H. P., Gessner U., Oehlert W., Gerok W. Intrahepatische Cholestase durch N-Propyl-Ajmalin. Dtsch Med Wochenschr. 1976 Apr 30;101(18):699–703. doi: 10.1055/s-0028-1104163. [DOI] [PubMed] [Google Scholar]
  2. Bussmann W. D., Müller E., Hänel H. J., Kaltenbach M. Orally administered prajmalium bitartrate in acute and chronic ventricular arrhythmias. Am J Cardiol. 1978 Mar;41(3):577–583. doi: 10.1016/0002-9149(78)90018-8. [DOI] [PubMed] [Google Scholar]
  3. Campbell C. B., McGuffie C., Weedon A. P., Powell L. W. Cholestatic liver disease associated with diphenylhydantoin therapy. Possible pathogenic importance of altered bile salt metabolism. Am J Dig Dis. 1977 Mar;22(3):255–262. doi: 10.1007/BF01072286. [DOI] [PubMed] [Google Scholar]
  4. Douglas S. D. Electron microscopic and functional aspects of human lymphocyte response to mitogens. Transplant Rev. 1972;11:39–59. doi: 10.1111/j.1600-065x.1972.tb00045.x. [DOI] [PubMed] [Google Scholar]
  5. Kuritzky A., Livni E., Munitz H., Englander T., Tyano S., Wijsenbeek H., Joshua H., Kott E. Cell-mediated immunity to human myelin basic protein in schizophrenic patients. J Neurol Sci. 1976 Dec;30(2-3):369–373. doi: 10.1016/0022-510x(76)90140-4. [DOI] [PubMed] [Google Scholar]
  6. Lindner H., Weber D., Klöppel G. Prajmaliumbitartrat-induzierte Leberschäden. Dtsch Med Wochenschr. 1976 Dec 17;101(51):1876–1880. doi: 10.1055/s-0028-1104362. [DOI] [PubMed] [Google Scholar]
  7. Myers B. D., Griffel B., Naveh D., Jankielowiiz T., Klajman A. Membrano-proliferative glomerulonephritis associated with persistent viral hepatitis. Am J Clin Pathol. 1973 Aug;60(2):222–228. doi: 10.1093/ajcp/60.2.222. [DOI] [PubMed] [Google Scholar]
  8. Perez V., Schaffner F., Popper H. Hepatic drug reactions. Prog Liver Dis. 1972;4:597–625. [PubMed] [Google Scholar]
  9. Rajapakse D. A., Glynn L. E. Macrophage migration inhibition test using guinea-pig macrophages and human lymphocytes. Nature. 1970 May 30;226(5248):857–858. doi: 10.1038/226857a0. [DOI] [PubMed] [Google Scholar]
  10. Samuels A. M., Carey M. C. Effects of chlorpromazine hydrochloride and its metabolites on Mg2+- and Na+,K+-ATPase activities of canalicular-enriched rat liver plasma membranes. Gastroenterology. 1978 Jun;74(6):1183–1190. [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES